4th Annual Lysosomal Disease Summit
2–3 October 2026 • Melbourne, Australia
The Lysosomal Disease Summit brings together clinicians, researchers, industry leaders, and patient advocates in harmonious collaboration, uniting to advance diagnostics, therapeutic innovation, and compassionate, patient-centred care across the lysosomal disease field. The Summit serves as a vibrant forum, orchestrating progress in clinical practice, translational research, and therapeutic discovery across the full spectrum of lysosomal diseases.
Review the 2025 Summit
View the 2025 agenda, meet our course directors, and discover the sponsors who made this event possible.
What to Expect in 2026
- Expert-led sessions on diagnostics, treatment development, and clinical insights
- High-scoring oral and poster abstracts from global researchers
- Panels, roundtables, and cross-disciplinary discussions
- APAC-focused and international perspectives on lysosomal disease care
Who Should Attend
The Summit welcomes professionals working across the lysosomal and metabolic disease landscape, including:
- Clinicians involved in diagnosis, treatment planning, and long-term patient management
- Researchers and scientists advancing basic, translational, and clinical studies
- Early-career investigators, trainees, and fellows seeking exposure to current research, mentorship, and global collaboration
- Industry partners contributing to therapeutic development, regulatory strategy, medical affairs, or clinical operations
- Advocacy leaders and patient-group representatives supporting education, access, and community engagement
- Allied health practitioners involved in multidisciplinary care
We respectfully acknowledge the Traditional Owners of the land on which the Lysosomal Disease Summit will take place, the Wurundjeri Woi Wurrung people of the Kulin Nation, and pay our respects to their Elders past and present. We recognise their continuing connection to land, waters, and culture.
Thank You, 2025 Summit Sponsors
